Characterization of cxorf21 Provides Molecular Insight Into Female-Bias Immune Response in SLE Pathogenesis

Valerie M. Harris,Kristi A. Koelsch,Biji T. Kurien,Isaac T. W. Harley,Jonathan D. Wren,John B. Harley,R. Hal Scofield
DOI: https://doi.org/10.3389/fimmu.2019.02160
IF: 7.3
2019-10-21
Frontiers in Immunology
Abstract:<span><strong>Background:</strong> Ninety percent of systemic lupus erythematosus (SLE) patients are women. X chromosome-dosage increases susceptibility to SLE and primary Sjögren's syndrome (pSS). Chromosome X open reading frame 21 <i>(CXorf21)</i> escapes X-inactivation and is an SLE risk gene of previously unknown function. We undertook the present study to delineate the function of CXorf21 in the immune system as well as investigate a potential role in the sex bias of SLE and pSS.<strong>Methods:</strong> Western blot protein analysis, qPCR, BioPlex cytokine immunoassay, pHrodo™ assays, as well as <i>in vitro</i> CRISPR-Cas9 knockdown experiments were employed to delineate the role of CXorf21 in relevant immunocytes.<strong>Results:</strong> Expressed in monocytes and B cells, <i>CXorf21</i> basal Mrna, and protein expression levels are elevated in female primary monocytes, B cells, and EBV-transformed B cells compared to male cells. We also found <i>CXorf21</i> mRNA and protein expression is higher in both male and female cells from SLE patients compared to control subjects. TLR7 ligation increased CXorf21 protein expression and <i>CXorf21</i> knockdown abrogated TLR7-driven increased <i>IFNA1</i> mRNA expression, and reduced secretion of both TNF-alpha and IL-6 in healthy female monocytes. Similarly, we found increased pH in the lysosomes of <i>CXorf21</i>-deficient female monocytes.<strong>Conclusion:</strong> CXorf21 is more highly expressed in female compared to male cells and is involved in a sexually dimorphic response to TLR7 activation. In addition, CXorf21 expression regulates lysosomal pH in a sexually dimorphic manner. Thus, sexually dimorphic expression of CXorf21 skews cellular immune responses in manner consistent with expected properties of a mediator of the X chromosome dose risk in SLE and pSS.</span>
immunology
What problem does this paper attempt to address?